Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function
- PMID: 20580019
- PMCID: PMC2948620
- DOI: 10.1016/j.jpeds.2010.05.018
Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function
Abstract
Objective: To assess the relative contributions of environmental and genetic factors to variation in cystic fibrosis (CF) lung disease.
Study design: Genetic and environmental contributions were quantified by use of intrapair correlations and differences in CF-specific forced expiratory volume in 1 second measures from 134 monozygous twins and 272 dizygous twins and siblings while in different living environments (ie, living with parents vs living alone), as well as by use of intraindividual differences in pulmonary function from a separate group of 80 siblings.
Results: Pulmonary function among monozygous twins was more similar than among dizygous twin and sibling pairs, regardless of living environment, affirming the role of genetic modifiers in CF pulmonary function. Regression modeling revealed that genetic factors account for 50% of pulmonary function variation, unique environmental or stochastic factors (36%), and shared environmental factors (14%; P < .0001). The intraindividual analysis produced similar estimates for the contributions of the unique and shared environment. The shared environment effects appeared primarily because of living with a sibling with CF (P = .003), rather than factors within the parental household (P = .310).
Conclusions: Genetic and environmental factors contribute equally to pulmonary function variation in CF. Environmental effects are dominated by unique and stochastic effects rather than common exposures.
Copyright © 2010 Mosby, Inc. All rights reserved.
Figures





Similar articles
-
Heritability of lung disease severity in cystic fibrosis.Am J Respir Crit Care Med. 2007 May 15;175(10):1036-43. doi: 10.1164/rccm.200608-1164OC. Epub 2007 Mar 1. Am J Respir Crit Care Med. 2007. PMID: 17332481 Free PMC article.
-
Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics.Twin Res. 2000 Dec;3(4):277-93. doi: 10.1375/136905200320565256. Twin Res. 2000. PMID: 11463149
-
Genetic modifiers of nutritional status in cystic fibrosis.Am J Clin Nutr. 2012 Dec;96(6):1299-308. doi: 10.3945/ajcn.112.043406. Epub 2012 Nov 7. Am J Clin Nutr. 2012. PMID: 23134884 Free PMC article.
-
Modifier genetics: cystic fibrosis.Annu Rev Genomics Hum Genet. 2005;6:237-60. doi: 10.1146/annurev.genom.6.080604.162254. Annu Rev Genomics Hum Genet. 2005. PMID: 16124861 Review.
-
Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.Paediatr Drugs. 2005;7(6):353-63. doi: 10.2165/00148581-200507060-00004. Paediatr Drugs. 2005. PMID: 16356023 Review.
Cited by
-
Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis.J Bras Pneumol. 2013 May-Jun;39(3):306-16. doi: 10.1590/S1806-37132013000300007. J Bras Pneumol. 2013. PMID: 23857699 Free PMC article.
-
Clinical expression of cystic fibrosis in a large cohort of Italian siblings.BMC Pulm Med. 2018 Dec 22;18(1):196. doi: 10.1186/s12890-018-0766-6. BMC Pulm Med. 2018. PMID: 30577776 Free PMC article.
-
Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.BMC Med Genet. 2014 Mar 4;15:27. doi: 10.1186/1471-2350-15-27. BMC Med Genet. 2014. PMID: 24593045 Free PMC article.
-
Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.Expert Rev Respir Med. 2022 Jun;16(6):637-650. doi: 10.1080/17476348.2022.2090928. Epub 2022 Jun 23. Expert Rev Respir Med. 2022. PMID: 35705523 Free PMC article. Review.
-
The Impact of Air Pollution on the Course of Cystic Fibrosis: A Review.Front Physiol. 2022 Jun 2;13:908230. doi: 10.3389/fphys.2022.908230. eCollection 2022. Front Physiol. 2022. PMID: 35721541 Free PMC article. Review.
References
-
- Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066–73. - PubMed
-
- Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245:1073–80. - PubMed
-
- Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol. 2001 Jan;31:1–12. - PubMed
-
- Kerem E, Corey M, Kerem B-S, Rommens J, Markiewicz D, Levison H, et al. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (deltaF508) N Engl J Med. 1990;323:1517–22. - PubMed
-
- Cystic Fibrosis Genotype/Phenotype Consortium Correlation between genotype and phenotype in cystic fibrosis. N Engl J Med. 1993;329:1308–13. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical